Specifically, their results showed that CCR9-knockout mice were more susceptible to DSS-induced colitis compared to wild-type controls, and that a dysregulated Th-17 immune response involving different macrophage subsets was observed during their recovery period following DSS treatment. Here, CCR9 is linked to colitis.